The Medicinal Products Act No 93/1994. Available at:. http://eng.heilbrigdisraduneyti.is/media/Laws%20in%20english/The_Medicinal_Products_Act_No_93-1994.pdf Accessed 29.10.07
DIRECTIVE 2001/83/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 6 November 2001 on the Community code relating to medicinal products for human use
L 311/67-128. Available at: Accessed 29.10.07
DIRECTIVE 2001/83/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 6 November 2001 on the Community code relating to medicinal products for human use. L 311/67-128. Available at:. Official J Eur Commun (2001). http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2001_83/dir_2001_83_en.pdf Accessed 29.10.07
Introduction: the challenge and promise of focus groups
Barbour R.S., and Kitzinger J. (Eds), Sage, London
Kitzinger J., and Barbour R.S. Introduction: the challenge and promise of focus groups. In: Barbour R.S., and Kitzinger J. (Eds). Developing Focus Group Research (1999), Sage, London
Hálfdanarson G., and Kristjánsson S. (Eds), University of Iceland Social Science Research Institute, Reykjavík
Gunnlaugsson G. Population and migration patterns 1880-1990. In: Hálfdanarson G., and Kristjánsson S. (Eds). Icelandic Societal Development 1880-1990: Essays (in Icelandic.) (1993), University of Iceland Social Science Research Institute, Reykjavík 109
The Pharmakon Phenomenon: cultural conceptions of drugs and drug use
Davis P. (Ed), Oxford University Press, New York
Montagne M. The Pharmakon Phenomenon: cultural conceptions of drugs and drug use. In: Davis P. (Ed). Contested Ground (1996), Oxford University Press, New York